◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › MET

MetLife Inc (MET) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

FINANCIAL SERVICES · Life & Health Insurance · DATA UPDATED 2026-07-14

MetLife Inc (MET) operates in the Life & Health Insurance industry and is headquartered in New York, United States with about 46,000 employees. Its market capitalization is roughly $61 billion. In the fiscal year ended 2025-12-31, MET reported $77.1B in revenue and $3.4B in net income.

MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates in six segments: Group Benefits; Retirement and Income Solutions; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings.

Interactive charts & full statements → Open the MET valuation workbench →

MET Revenue & Earnings History — Annual Income Statement

Income statementTTM → 2026-03-312025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Total Revenue$76.9B$77.1B$71.0B$67.7B$68.0B$63.4B$67.9B$69.6B$67.9B$62.3B$60.5B$61.3B$73.3B$68.2B$66.3B$70.2B$52.2B$41.1B$51.0B$53.0B$48.3B
Gross Profit$21.9B$28.0B$20.0B$17.3B$18.9B$16.8B$15.5B$16.2B$15.9B$13.5B$14.0B$16.2B$21.8B$17.5B$15.8B$23.8B$14.5B$7.9B$18.8B$53.0B$12.8B
Gross Margin %28.4%36.4%28.2%25.5%27.9%26.6%22.8%23.2%23.4%21.6%23.1%26.4%29.7%25.6%23.8%33.9%27.8%19.2%36.8%100.0%26.6%
Operating Income (EBIT)$4.8B$4.7B$6.7B$2.2B$6.4B$8.5B$6.9B$6.8B$6.3B$3.5B$4.3B$5.7B$8.8B$4.1B$1.4B$9.2B$3.7B($4.3B)$5.1B$7.2B$4.2B
Operating Margin %6.3%6.0%9.4%3.2%9.4%13.4%10.2%9.8%9.3%5.7%7.1%9.2%12.0%5.9%2.2%13.1%7.1%-10.6%9.9%13.6%8.6%
Net Income$3.6B$3.4B$4.4B$1.6B$5.3B$6.9B$5.4B$5.9B$5.1B$4.0B$850M$5.4B$6.3B$3.4B$1.3B$6.4B$2.7B($2.2B)$3.2B$4.3B$6.3B
Net Margin %4.7%4.4%6.2%2.3%7.8%10.8%8.0%8.5%7.5%6.4%1.4%8.8%8.6%4.9%2.0%9.1%5.1%-5.5%6.3%8.1%13.0%
EBITDA$5.9B$6.5B$7.4B$3.9B$8.0B$10.1B$8.5B$8.4B$8.1B$5.5B$6.1B$7.5B$10.7B$6.0B$3.4B$11.6B$6.0B($2.9B)$6.2B$7.2B$5.1B
Earnings Per Share (EPS)$5.44$5.08$6.22$2.07$6.53$7.88$5.92$6.25$5.05$3.84$0.78$4.76$5.57$3.00$1.21$6.07$2.71$-2.74$4.31$5.66$8.17
Shares Outstanding (M)656M665M711M762M809M869M913M944M1,014M1,044M1,096M1,128M1,132M1,122M1,092M1,058M986M818M745M762M771M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MET Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue$19.1B$23.8B$16.9B$17.2B$18.3B$18.4B$18.3B$17.5B
Gross Profit$7.1B$7.3B$2.9B$4.5B$4.7B$4.9B$5.4B$4.4B
Gross Margin %37.2%30.5%17.4%26.4%25.9%26.4%29.8%25.1%
Operating Income (EBIT)$1.5B$1.1B$1.2B$980M$1.4B$1.4B$2.0B$1.2B
Operating Margin %7.9%4.7%7.2%5.7%7.4%7.5%10.9%6.9%
Net Income$1.2B$809M$896M$729M$945M$1.3B$1.3B$946M
Net Margin %6.2%3.4%5.3%4.2%5.2%6.9%7.3%5.4%
EBITDA$1.8B$1.4B$1.5B$1.2B$1.6B$1.6B$2.3B$1.5B
Earnings Per Share (EPS)$1.81$1.22$1.34$1.08$1.38$1.82$1.91$1.32
Shares Outstanding (M)656M665M669M675M687M698M704M715M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MET Free Cash Flow History

Cash flowTTM → 2026-03-312025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Cash from Operations (CFO)$16.5B$18.1B$15.1B$14.3B$13.2B$12.6B$11.6B$13.8B$9.5B$12.7B$14.7B$13.3B$17.1B$17.6B$15.3B$9.6B$9.4B$3.8B$10.7B$9.9B$6.6B
Capital Expenditures (CapEx)$0M$0M$0M$1.2B$0M$4.4B$4.3B$5.7B$7.1B$4.6B$8.5B$5.6B$4.6B$3.4B$998M$1.3B$2.8B$579M$1.2B$0M$0M
Free Cash Flow (FCF)$16.5B$18.1B$15.1B$13.1B$13.2B$8.2B$7.4B$8.1B$2.5B$8.2B$6.1B$7.8B$12.5B$14.1B$14.3B$8.4B$6.5B$3.2B$9.5B$9.9B$6.6B
FCF Margin %21.5%23.5%21.3%19.3%19.4%13.0%10.9%11.7%3.6%13.1%10.1%12.7%17.0%20.7%21.5%11.9%12.5%7.8%18.7%18.7%13.7%
Dividends Paid$1.7B$1.7B$1.7B$1.8B$1.8B$1.8B$1.9B$1.8B$1.8B$1.8B$1.8B$1.8B$1.6B$1.2B$933M$909M$906M$732M$717M$678M$584M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MET Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Cash from Operations (CFO)$2.7B$8.1B$3.6B$2.2B$4.3B$5.1B$4.2B$3.5B
Free Cash Flow (FCF)$2.7B$8.1B$3.6B$2.2B$4.3B$5.1B$4.2B$3.5B
FCF Margin %14.1%34.0%21.1%12.7%23.3%27.8%22.8%20.0%
Dividends Paid$417M$406M$444M$413M$440M$410M$450M$423M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MET Balance Sheet History

Balance sheet2026-03-312025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Total Assets$743.2B$745.2B$677.5B$687.6B$663.1B$759.7B$795.1B$740.5B$687.5B$719.9B$898.8B$877.9B$902.3B$885.3B$836.8B$799.6B$730.9B$539.3B$501.7B$559.1B$527.7B
Cash & Cash Equivalents$22.7B$22.0B$20.1B$20.6B$20.2B$20.0B$19.8B$16.6B$15.8B$12.7B$12.7B$12.8B$10.8B$7.6B$15.7B$10.5B$13.0B$10.1B$24.2B$10.0B$7.1B
Total Liabilities$715.4B$716.2B$649.8B$657.3B$632.9B$692.0B$720.3B$674.1B$634.6B$661.0B$831.1B$809.4B$829.7B$822.3B$771.8B$748.4B$681.8B$505.8B$477.7B$524.0B$493.9B
Total Debt (Short + Long-Term)$20.0B$20.2B$18.7B$18.8B$18.0B$17.4B$4.4B$4.4B$4.5B$4.7B$7.5B$7.4B$7.5B$7.6B$7.5B$30.7B$36.4B$22.2B$20.7B$20.0B$15.2B
Total Shareholders' Equity$27.3B$28.4B$27.4B$30.0B$29.9B$67.5B$74.6B$66.1B$52.7B$58.7B$67.5B$67.9B$72.1B$61.6B$64.5B$57.5B$48.6B$33.1B$23.7B$35.2B$33.8B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive MET viewer.

Other Companies in Life & Health Insurance

← MESHAll stocksMETA →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.